Cargando…

TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma

Although TNFAIP8 overexpression has been implicated in several human cancers, its clinical significance and biological function in hepatocellular carcinoma (HCC) remains unknown. Our study demonstrated that TNFAIP8 overexpression in primary HCC samples correlated with TNM stage, recurrence, poor pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Qianze, Fu, Lin, Zhao, Yue, Xie, Chengyao, Li, Qingchang, Wang, Enhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362516/ https://www.ncbi.nlm.nih.gov/pubmed/28152516 http://dx.doi.org/10.18632/oncotarget.14938

Ejemplares similares

TNFAIP8 promotes cell growth by regulating the Hippo pathway in epithelial ovarian cancer
por: Xie, Yao, et al.
Publicado: (2018)

Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma
por: Guo, Qingping, et al.
Publicado: (2018)

Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer
por: Dong, Qianze, et al.
Publicado: (2017)

WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression
por: Han, Qiang, et al.
Publicado: (2021)

LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling
por: Cheng, Yang, et al.
Publicado: (2018)

POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
por: Rahmat, Muhammad Bakhait, et al.
Publicado: (2019)

Derlin-1 is a target to improve radiotherapy effect of esophageal squamous cell carcinoma
por: Dong, Qianze, et al.
Publicado: (2017)

An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2
por: Park, Gun-Soo, et al.
Publicado: (2016)

Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner
por: García-Gutiérrez, Lucía, et al.
Publicado: (2022)

The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer
por: Zheng, Xiaoying, et al.
Publicado: (2017)

Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
por: Rahmat, Muhammad Bakhait, et al.
Publicado: (2019)

TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation
por: Niture, Suryakant, et al.
Publicado: (2020)

TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
por: Pang, Yihua, et al.
Publicado: (2020)

A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
por: Azad, T., et al.
Publicado: (2018)

LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma
por: Guo, Chengyong, et al.
Publicado: (2019)

O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
por: Kim, Eunah, et al.
Publicado: (2020)

Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells
por: Darbankhales, Soroush, et al.
Publicado: (2020)

PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019)

Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase–mediated inhibitory phosphorylation of the transcriptional coactivator YAP
por: Thines, Louise, et al.
Publicado: (2022)

Lats2 Modulates Adipocyte Proliferation and Differentiation via Hippo Signaling
por: An, Yang, et al.
Publicado: (2013)

RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
por: Pan, Yi, et al.
Publicado: (2018)

Small molecule LATS kinase inhibitors block the Hippo signaling pathway and promote cell growth under 3D culture conditions
por: Aihara, Ayako, et al.
Publicado: (2022)

Susceptibility of TNFAIP8, TNFAIP8L1, and TNFAIP2 Gene Polymorphisms on Cancer Risk: A Comprehensive Review and Meta-Analysis of Case–Control Studies
por: Bhowmik, Khokon Kanti, et al.
Publicado: (2022)

TNFAIP8 promotes prostate cancer cell survival by inducing autophagy
por: Niture, Suryakant, et al.
Publicado: (2018)

LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
por: Gan, Wenjian, et al.
Publicado: (2020)

Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
por: Ma, Biao, et al.
Publicado: (2016)

DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins
por: Nguyen, Hung Thanh, et al.
Publicado: (2017)

miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2
por: Mohamed, Zeinab, et al.
Publicado: (2018)

Novel insights into the regulation of LATS2 kinase in prehierarchical follicle development via the Hippo pathway in hen ovary
por: Sun, Xue, et al.
Publicado: (2021)

Protocols for measuring phosphorylation, subcellular localization, and kinase activity of Hippo pathway components YAP and LATS in cultured cells
por: Luo, Min, et al.
Publicado: (2022)

MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells
por: Zhao, Yue, et al.
Publicado: (2017)

MicroRNA-93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarction
por: Ma, Chengjie, et al.
Publicado: (2020)

Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway
por: Wang, Chien-Hao, et al.
Publicado: (2023)

Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling
por: Hergovich, Alexander
Publicado: (2013)

TNFAIP8: Inflammation, Immunity and Human Diseases
por: Niture, Suryakant, et al.
Publicado: (2019)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma
por: Suzuki, Koya, et al.
Publicado: (2022)

Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1
por: Le, Truc Phan Hoang, et al.
Publicado: (2023)

FRMPD1 activates the Hippo pathway via interaction with WWC3 to suppress the proliferation and invasiveness of lung cancer cells
por: Rong, Xuezhu, et al.
Publicado: (2019)

Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
por: Gao, Yanping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h0e9dbjgg5mht7q887eajg356s